Development of antivirals and vaccines against enterovirus 71 (EV-A71)
| Main Author: | Poh, Chit Laa * |
|---|---|
| Format: | Book Section |
| Published: |
Sunway University Press
2018
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/799/ |
Similar Items
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)
by: Lalani, S.*, et al.
Published: (2021)
Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013)
by: Lui, Edmund Yan Long, et al.
Published: (2013)
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor
by: Tan, Chee Wah, et al.
Published: (2013)
by: Tan, Chee Wah, et al.
Published: (2013)
Inhibition of Enterovirus 71 (EV-71 infections by a novel
antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)
by: Tan, Chee Wah, et al.
Published: (2012)
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Characterization of significant molecular determinants of virulence of Enterovirus 71 sub-genotype B4 in Rhabdomyosarcoma cells
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Molecular docking of SP40 peptide towards cellular
receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)
by: Masomian, Malihe *, et al.
Published: (2021)
In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)
by: Pourianfar, Hamid Reza, et al.
Published: (2012)
Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)
by: Lim, Hui Xuan *, et al.
Published: (2019)
T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)
by: Wong, Siew Tung
Published: (2005)
Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)
by: Poh, Chit Laa *, et al.
Published: (2019)
Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)
by: Wei, Choong Ch'ng, et al.
Published: (2011)
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
The expression of recombinant
bacille calmette-guerin (rBCG) containing
VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)
by: Wey, Goh Kai
Published: (2008)
Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
by: Kirk, Kristin, et al.
Published: (2012)
by: Kirk, Kristin, et al.
Published: (2012)
Rational design of live attenuated vaccine by site-directed mutagenesis and deletion in the 5’- non coding region of the enterovirus 71(EV-A71) genome
by: Yee, Isabel Pin Tsin *
Published: (2015)
by: Yee, Isabel Pin Tsin *
Published: (2015)
In silico and in vitro antiviral activity evaluation of prodigiosin from Serratia marcescens against enterovirus 71
by: Muhamad Fakrulnizam Abd Aziz,, et al.
Published: (2022)
by: Muhamad Fakrulnizam Abd Aziz,, et al.
Published: (2022)
It's not killer EV71 unimas
by: The Borneo Post
Published: (2008)
by: The Borneo Post
Published: (2008)
Characterization of plaque variants and the involvement of Quasi-Species in a population of EV-A71
by: Mandary, M. B. *, et al.
Published: (2020)
by: Mandary, M. B. *, et al.
Published: (2020)
Development of peptide vaccines in dengue
by: Reginald, Kavita*, et al.
Published: (2017)
by: Reginald, Kavita*, et al.
Published: (2017)
Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)
by: Yee, Siew Fung.
Published: (2007)
Development of a diagnostic tool for the detection of antibodies against human enterovirus 71
by: Tan, Cheng Siang.
Published: (2004)
by: Tan, Cheng Siang.
Published: (2004)
Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice
by: Lalani, Salima, et al.
Published: (2021)
by: Lalani, Salima, et al.
Published: (2021)
Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)
by: Ooi, Mong How, et al.
Published: (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)
by: Solomon, Tom, et al.
Published: (2010)
Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease
by: Ong, Kien Chai, et al.
Published: (2010)
by: Ong, Kien Chai, et al.
Published: (2010)
Construction Of Recombinant Bcg Expressing The
Vp1 Antigen Of Enterovirus 71 For The Development
Of A Candidate Vaccine
by: Othman, Nurulhasanah
Published: (2006)
by: Othman, Nurulhasanah
Published: (2006)
Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)
Preliminary screening of potential antiviral peptide targeting EV71 virus particles using phage display peptide library
by: Tan, Sin Shen
Published: (2010)
by: Tan, Sin Shen
Published: (2010)
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
by: David, Perera, et al.
Published: (2004)
by: David, Perera, et al.
Published: (2004)
PNMA family: Protein interaction network and cell signalling pathways implicated in cancer and apoptosis
by: Pang, Siew Wai *, et al.
Published: (2018)
by: Pang, Siew Wai *, et al.
Published: (2018)
Immunogenicity study of dna vaccine and
dna vaccine carrier expressing vp1 of enterovirus
71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)
by: Nur Ayuni, Kadir
Published: (2008)
Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model
by: Ch'ng, Wei Choong
Published: (2010)
by: Ch'ng, Wei Choong
Published: (2010)
Pluripotent human embryonic stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy
by: Yap, May Shin *, et al.
Published: (2016)
by: Yap, May Shin *, et al.
Published: (2016)
Similar Items
-
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020) -
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021) -
Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013) -
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016) -
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor
by: Tan, Chee Wah, et al.
Published: (2013)